IDEAYA Biosciences
CompanyUnited StatesFounded 2015
IDEAYA Biosciences develops one asset, in phase 1 (IDE161 in solid tumour). Mostly small molecule acting on DNA damage response, DNA repair and PARG; based in the United States, founded in 2015.
- 1
- Asset
- Furthest stage
- Phase 1
- 2
- Trials
- 0
- Signals
Pipeline
1Small-molecule poly(ADP-ribose) glycohydrolase inhibitor disrupting DNA damage repair.
Phase 1, Small molecule, DNA damage response, DNA repair, solid tumour
Full company profiles: pipeline, trials, funding and people.
In the full profile
- Evidence behind the mechanisms2
- Trials2
- Deals1
- Similar companies6